176 related articles for article (PubMed ID: 35280799)
1. A Predictive Model of 2yDFS During MR-Guided RT Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients.
Chiloiro G; Boldrini L; Preziosi F; Cusumano D; Yadav P; Romano A; Placidi L; Lenkowicz J; Dinapoli N; Bassetti MF; Gambacorta MA; Valentini V
Front Oncol; 2022; 12():831712. PubMed ID: 35280799
[TBL] [Abstract][Full Text] [Related]
2. Delta Radiomic Analysis of Mesorectum to Predict Treatment Response and Prognosis in Locally Advanced Rectal Cancer.
Chiloiro G; Cusumano D; Romano A; Boldrini L; Nicolì G; Votta C; Tran HE; Barbaro B; Carano D; Valentini V; Gambacorta MA
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370692
[TBL] [Abstract][Full Text] [Related]
3. Radiomics-enhanced early regression index for predicting treatment response in rectal cancer: a multi-institutional 0.35 T MRI-guided radiotherapy study.
Boldrini L; Chiloiro G; Cusumano D; Yadav P; Yu G; Romano A; Piras A; Votta C; Placidi L; Broggi S; Catucci F; Lenkowicz J; Indovina L; Bassetti MF; Yang Y; Fiorino C; Valentini V; Gambacorta MA
Radiol Med; 2024 Apr; 129(4):615-622. PubMed ID: 38512616
[TBL] [Abstract][Full Text] [Related]
4. Delta radiomics for rectal cancer response prediction using low field magnetic resonance guided radiotherapy: an external validation.
Cusumano D; Boldrini L; Yadav P; Yu G; Musurunu B; Chiloiro G; Piras A; Lenkowicz J; Placidi L; Romano A; De Luca V; Votta C; Barbaro B; Gambacorta MA; Bassetti MF; Yang Y; Indovina L; Valentini V
Phys Med; 2021 Apr; 84():186-191. PubMed ID: 33901863
[TBL] [Abstract][Full Text] [Related]
5. Delta Radiomics Analysis for Local Control Prediction in Pancreatic Cancer Patients Treated Using Magnetic Resonance Guided Radiotherapy.
Cusumano D; Boldrini L; Yadav P; Casà C; Lee SL; Romano A; Piras A; Chiloiro G; Placidi L; Catucci F; Votta C; Mattiucci GC; Indovina L; Gambacorta MA; Bassetti M; Valentini V
Diagnostics (Basel); 2021 Jan; 11(1):. PubMed ID: 33466307
[TBL] [Abstract][Full Text] [Related]
6. Delta radiomics for rectal cancer response prediction with hybrid 0.35 T magnetic resonance-guided radiotherapy (MRgRT): a hypothesis-generating study for an innovative personalized medicine approach.
Boldrini L; Cusumano D; Chiloiro G; Casà C; Masciocchi C; Lenkowicz J; Cellini F; Dinapoli N; Azario L; Teodoli S; Gambacorta MA; De Spirito M; Valentini V
Radiol Med; 2019 Feb; 124(2):145-153. PubMed ID: 30374650
[TBL] [Abstract][Full Text] [Related]
7. External validation and comparison of MR-based radiomics models for predicting pathological complete response in locally advanced rectal cancer: a two-centre, multi-vendor study.
Wei Q; Chen Z; Tang Y; Chen W; Zhong L; Mao L; Hu S; Wu Y; Deng K; Yang W; Liu X
Eur Radiol; 2023 Mar; 33(3):1906-1917. PubMed ID: 36355199
[TBL] [Abstract][Full Text] [Related]
8. MRI-based pre-Radiomics and delta-Radiomics models accurately predict the post-treatment response of rectal adenocarcinoma to neoadjuvant chemoradiotherapy.
Wang L; Wu X; Tian R; Ma H; Jiang Z; Zhao W; Cui G; Li M; Hu Q; Yu X; Xu W
Front Oncol; 2023; 13():1133008. PubMed ID: 36925913
[TBL] [Abstract][Full Text] [Related]
9. Radiomics-based prediction of two-year clinical outcome in locally advanced cervical cancer patients undergoing neoadjuvant chemoradiotherapy.
Autorino R; Gui B; Panza G; Boldrini L; Cusumano D; Russo L; Nardangeli A; Persiani S; Campitelli M; Ferrandina G; Macchia G; Valentini V; Gambacorta MA; Manfredi R
Radiol Med; 2022 May; 127(5):498-506. PubMed ID: 35325372
[TBL] [Abstract][Full Text] [Related]
10. Delta Radiomics Can Predict Distant Metastasis in Locally Advanced Rectal Cancer: The Challenge to Personalize the Cure.
Chiloiro G; Rodriguez-Carnero P; Lenkowicz J; Casà C; Masciocchi C; Boldrini L; Cusumano D; Dinapoli N; Meldolesi E; Carano D; Damiani A; Barbaro B; Manfredi R; Valentini V; Gambacorta MA
Front Oncol; 2020; 10():595012. PubMed ID: 33344243
[TBL] [Abstract][Full Text] [Related]
11. MRI-based delta-radiomics are predictive of pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Wan L; Peng W; Zou S; Ye F; Geng Y; Ouyang H; Zhao X; Zhang H
Acad Radiol; 2021 Nov; 28 Suppl 1():S95-S104. PubMed ID: 33189550
[TBL] [Abstract][Full Text] [Related]
12. Fractal-Based Radiomic Approach to Tailor the Chemotherapy Treatment in Rectal Cancer: A Generating Hypothesis Study.
Di Dio C; Chiloiro G; Cusumano D; Catucci F; Boldrini L; Romano A; Meldolesi E; Marazzi F; Corvari B; Barbaro B; Manfredi R; Valentini V; Gambacorta MA
Front Oncol; 2021; 11():774413. PubMed ID: 34956893
[TBL] [Abstract][Full Text] [Related]
13. A multiple-time-scale comparative study for the added value of magnetic resonance imaging-based radiomics in predicting pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Peng W; Wan L; Wang S; Zou S; Zhao X; Zhang H
Front Oncol; 2023; 13():1234619. PubMed ID: 37664046
[TBL] [Abstract][Full Text] [Related]
14. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
[TBL] [Abstract][Full Text] [Related]
15. MRI-Based Radiomics Predicts Tumor Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
Yi X; Pei Q; Zhang Y; Zhu H; Wang Z; Chen C; Li Q; Long X; Tan F; Zhou Z; Liu W; Li C; Zhou Y; Song X; Li Y; Liao W; Li X; Sun L; Pei H; Zee C; Chen BT
Front Oncol; 2019; 9():552. PubMed ID: 31293979
[No Abstract] [Full Text] [Related]
16. Feasibility of delta radiomics-based pCR prediction for rectal cancer patients treated with magnetic resonance-guided adaptive radiotherapy.
Wu J; Xiao J; Li Y; Wu F; Peng Q; Li C; Tang B; Orlandini LC
Front Oncol; 2023; 13():1230519. PubMed ID: 38074653
[TBL] [Abstract][Full Text] [Related]
17. MRI-based radiomics to predict neoadjuvant chemoradiotherapy outcomes in locally advanced rectal cancer: A multicenter study.
Xiang Y; Li S; Wang H; Song M; Hu K; Wang F; Wang Z; Niu Z; Liu J; Cai Y; Li Y; Zhu X; Geng J; Zhang Y; Teng H; Wang W
Clin Transl Radiat Oncol; 2023 Jan; 38():175-182. PubMed ID: 36471751
[TBL] [Abstract][Full Text] [Related]
18. Predicting pathological complete response by comparing MRI-based radiomics pre- and postneoadjuvant radiotherapy for locally advanced rectal cancer.
Li Y; Liu W; Pei Q; Zhao L; Güngör C; Zhu H; Song X; Li C; Zhou Z; Xu Y; Wang D; Tan F; Yang P; Pei H
Cancer Med; 2019 Dec; 8(17):7244-7252. PubMed ID: 31642204
[TBL] [Abstract][Full Text] [Related]
19. Development of a Joint Prediction Model Based on Both the Radiomics and Clinical Factors for Predicting the Tumor Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer.
Liu Y; Zhang FJ; Zhao XX; Yang Y; Liang CY; Feng LL; Wan XB; Ding Y; Zhang YW
Cancer Manag Res; 2021; 13():3235-3246. PubMed ID: 33880066
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of an MRI-based radiomic nomogram to distinguish between good and poor responders in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy.
Wang J; Liu X; Hu B; Gao Y; Chen J; Li J
Abdom Radiol (NY); 2021 May; 46(5):1805-1815. PubMed ID: 33151359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
